Activation of the thromboxane A2 pathway in human prostate cancer correlates with tumor Gleason score and pathologic stage

European Urology
Thibaut DassesseDavid Waltregny

Abstract

We investigated the potential involvement of the thromboxane A(2) (TXA(2)) pathway in human prostate cancer (PCa). Expression of cyclooxygenase-2 (COX-2), TXA(2) synthase (TXS), and TXA(2) receptors (TPRs), the main actors of the TXA(2) pathway, was analyzed on serial tissue sections from 46 human PCa specimens. The expression levels of COX-2, TXS, and TPRs were significantly higher in malignant than in corresponding nontumoral prostatic epithelial cells. Increased immunoreactivity for these antigens was also observed in high-grade prostate intraepithelial neoplasia (HGPIN) glands. COX-2, TXS, and TPR proteins usually displayed a coordinated overexpression pattern in PCa lesions, as assessed in serial tissue sections. Increased levels of these proteins in the tumors were all significantly associated with higher Gleason scores and pathologic stages. Proteins specifically involved in the TXA(2) pathway are up-regulated in human PCa and their level of expression is associated with tumor extraprostatic extension and loss of differentiation. Our study is the first to examine simultaneously all key proteins involved in this pathway including TXA(2) receptors and results suggest that the TXA(2) pathway may be a potential target for PC...Continue Reading

References

May 1, 1993·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·J A RossR K Severson
Jul 8, 1993·The New England Journal of Medicine·A A Nanji
Jan 1, 1997·Virchows Archiv : an International Journal of Pathology·D G Bostwick, R Montironi
May 23, 1998·Annual Review of Pharmacology and Toxicology·J R VaneR M Botting
Oct 28, 1998·Journal of the National Cancer Institute·M M Taketo
Aug 10, 2000·Cancer·R YoshimuraS Wada
Aug 24, 2000·International Journal of Cancer. Journal International Du Cancer·F A van den BrûleV Castronovo
Aug 15, 2001·Urology·A KirschenbaumA C Levine
Nov 16, 2001·Biochemical Society Transactions·B T Kinsella
Mar 22, 2003·Lancet·Angelo M DeMarzoJonathan I Epstein
Oct 30, 2003·The Journal of Biological Chemistry·François ValentinJohn R Tippins
Dec 17, 2003·Journal of Thrombosis and Haemostasis : JTH·T ArisatoI Maruyama
Feb 18, 2004·Current Cancer Drug Targets·Chinthalapally V Rao, Bandaru S Reddy
May 20, 2004·European Urology·Kati P Porkka, Tapio Visakorpi
May 27, 2004·JAMA : the Journal of the American Medical Association·Mary Beth TerryAlfred I Neugut
Jun 5, 2004·Seminars in Oncology·Stephen Gately, William W Li
Jul 16, 2004·Seminars in Oncology·Claus-Henning Koehne, Raymond N Dubois
Dec 2, 2004·Journal of the National Cancer Institute·Cori Vanchieri
Feb 16, 2005·Current Opinion in Gastroenterology·Paul James Fortun, Christopher John Hawkey
Mar 1, 2005·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Bernard Bannwarth
Apr 13, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Hanna RennertTimothy R Rebbeck
Aug 19, 2005·International Journal of Cancer. Journal International Du Cancer·Michaël ChapletAkeila Bellahcène

❮ Previous
Next ❯

Citations

Oct 22, 2011·Cancer Metastasis Reviews·Isabelle M BerquinYong Q Chen
Aug 1, 2008·Future Lipidology·Kasem Nithipatikom, William B Campbell
May 15, 2012·Progress in Lipid Research·Inês Cebola, Miguel A Peinado
Oct 11, 2011·Prostaglandins & Other Lipid Mediators·Omar MoussaPerry V Halushka
Nov 4, 2010·European Journal of Pharmacology·Frank StrittmatterMartin Hennenberg
Feb 1, 2014·Biochimica Et Biophysica Acta·Mary Clare CathcartGraham P Pidgeon
Dec 15, 2010·Biochimica Et Biophysica Acta·Run-Yue Huang, George G Chen
Feb 4, 2010·Biochimica Et Biophysica Acta·Mary-Clare CathcartGraham P Pidgeon
Aug 6, 2018·Cancer Metastasis Reviews·Athanassios A PanagiotopoulosMarilena Kampa
Jan 15, 2010·Ultrastructural Pathology·Mamta GuptaG Petur Nielsen
May 18, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Jian WangZhi-Wei He
Aug 17, 2012·International Journal of Oncology·Peiying YangJeri Kim
Dec 5, 2020·Prostaglandins, Leukotrienes, and Essential Fatty Acids·Jean-François BilodeauVincent Fradet
May 1, 2021·Frontiers in Cardiovascular Medicine·Mario Álvarez-MaestroMercedes Ferrer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.